These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 3978640

  • 1. Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas.
    Fodstad O, Aamdal S, Pihl A, Boyd MR.
    Cancer Res; 1985 Apr; 45(4):1778-86. PubMed ID: 3978640
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
    Bernacki RJ, Oberman EJ, Seweryniak KE, Atwood A, Bergeron RJ, Porter CW.
    Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
    [Abstract] [Full Text] [Related]

  • 5. Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors.
    Dexter DL, Hesson DP, Ardecky RJ, Rao GV, Tippett DL, Dusak BA, Paull KD, Plowman J, DeLarco BM, Narayanan VL.
    Cancer Res; 1985 Nov; 45(11 Pt 1):5563-8. PubMed ID: 4053030
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic response of human tumor xenografts in athymic mice to doxorubicin.
    Giuliani FC, Zirvi KA, Kaplan NO.
    Cancer Res; 1981 Jan; 41(1):325-35. PubMed ID: 7448772
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
    McRipley RJ, Burns-Horwitz PE, Czerniak PM, Diamond RJ, Diamond MA, Miller JL, Page RJ, Dexter DL, Chen SF, Sun JH.
    Cancer Res; 1994 Jan 01; 54(1):159-64. PubMed ID: 8261436
    [Abstract] [Full Text] [Related]

  • 8. Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent.
    Hickman JA, Stevens MF, Gibson NW, Langdon SP, Fizames C, Lavelle F, Atassi G, Lunt E, Tilson RM.
    Cancer Res; 1985 Jul 01; 45(7):3008-13. PubMed ID: 4005840
    [Abstract] [Full Text] [Related]

  • 9. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N, Nagasu T, Fujita F, Watanabe T, Tsukahara K, Funahashi Y, Fujita M, Taguchi T, Yoshino H, Kitoh K.
    Cancer Res; 1994 Apr 01; 54(7):1702-6. PubMed ID: 8137285
    [Abstract] [Full Text] [Related]

  • 10. Activity of thymidine as a chemotherapeutic agent against human tumor xenografts in nude mice.
    Howell SB, Jenkins RS, Streifel J.
    Cancer Res; 1979 Oct 01; 39(10):3875-80. PubMed ID: 476623
    [Abstract] [Full Text] [Related]

  • 11. [Preclinical screening of chemotherapeutic and endocrine agents using human tumor xenografts--nude mouse system].
    Kubota T, Ishibiki K, Abe O.
    Gan To Kagaku Ryoho; 1991 Jul 01; 18(9):1439-47. PubMed ID: 1854214
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
    Utsugi T, Shibata J, Sugimoto Y, Aoyagi K, Wierzba K, Kobunai T, Terada T, Oh-hara T, Tsuruo T, Yamada Y.
    Cancer Res; 1996 Jun 15; 56(12):2809-14. PubMed ID: 8665518
    [Abstract] [Full Text] [Related]

  • 13. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.
    Geiger T, Müller M, Monia BP, Fabbro D.
    Clin Cancer Res; 1997 Jul 15; 3(7):1179-85. PubMed ID: 9815797
    [Abstract] [Full Text] [Related]

  • 14. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Lee FY, Borzilleri R, Fairchild CR, Kim SH, Long BH, Reventos-Suarez C, Vite GD, Rose WC, Kramer RA.
    Clin Cancer Res; 2001 May 15; 7(5):1429-37. PubMed ID: 11350914
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo anticancer activity of mitozolomide and sparsomycin in human tumor xenografts, murine tumors and human bone marrow.
    Fiebig HH, Berger DP, Köpping K, Ottenheijm HC, Zylicz Z.
    J Cancer Res Clin Oncol; 1990 May 15; 116(6):550-6. PubMed ID: 2254373
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV, Price JE, Glinsky VV, Mossine VV, Kiriakova G, Metcalf JB.
    Cancer Res; 1996 Dec 01; 56(23):5319-24. PubMed ID: 8968076
    [Abstract] [Full Text] [Related]

  • 19. Preclinical antitumor activity of an alpha-picoline derivative, penclomedine (NSC 338720), on human and murine tumors.
    Plowman J, Harrison SD, Dykes DJ, Paull KD, Narayanan VL, Tobol HK, Martin J, Griswold DP.
    Cancer Res; 1989 Apr 15; 49(8):1909-15. PubMed ID: 2702634
    [Abstract] [Full Text] [Related]

  • 20. Reduced antineoplastic activity in mice of cisplatin administered with high salt concentration in the vehicle.
    Aamdal S, Fodstad O, Kaalhus O, Pihl A.
    J Natl Cancer Inst; 1984 Sep 15; 73(3):743-52. PubMed ID: 6590919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.